|
1
|
Dibner C, Schibler U and Albrecht U: The
mammalian circadian timing system: Organization and coordination of
central and peripheral clocks. Annu Rev Physiol. 72:517–549. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Welsh DK, Yoo SH, Liu AC, Takahashi JS and
Kay SA: Bioluminescence imaging of individual fibroblasts reveals
persistent, independently phased circadian rhythms of clock gene
expression. Curr Biol. 14:2289–2295. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takahashi JS: Transcriptional architecture
of the mammalian circadian clock. Nat Rev Genet. 18:164–179. 2017.
View Article : Google Scholar
|
|
4
|
Miller BH, McDearmon EL, Panda S, Hayes
KR, Zhang J, Andrews JL, Antoch MP, Walker JR, Esser KA, Hogenesch
JB, et al: Circadian and CLOCK-controlled regulation of the mouse
transcriptome and cell proliferation. Proc Natl Acad Sci USA.
104:3342–3347. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Matsuo T, Yamaguchi S, Mitsui S, Emi A,
Shimoda F and Okamura H: Control mechanism of the circadian clock
for timing of cell division in vivo. Science. 302:255–259. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu Z, Hua B, Shang Z, Yuan G, Xu L, Li E,
Li X, Sun N, Yan Z, Qian R, et al: Altered clock and lipid
metabolism-related genes in atherosclerotic mice kept with abnormal
lighting condition. BioMed Res Int. 2016:54385892016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Di Cara F and King-Jones K: The circadian
clock is a key driver of steroid hormone production in Drosophila.
Curr Biol. 26:2469–2477. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Terry EE, Fejer E, Gamba D, Hartmann
N, Logsdon J, Michalski D, Rois LE, Scuderi MJ, Kunst M, et al:
Achilles is a circadian clock-controlled gene that regulates immune
function in Drosophila. Brain Behav Immun. 61:127–136. 2017.
View Article : Google Scholar
|
|
9
|
Tao H, Li X, Qiu JF, Cui WZ, Sima YH and
Xu SQ: Inhibition of expression of the circadian clock gene period
causes metabolic abnormalities including repression of
glycometabolism in Bombyx mori cells. Sci Rep. 7:462582017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vieira E, Ruano E, Figueroa AL, Aranda G,
Momblan D, Carmona F, Gomis R, Vidal J and Hanzu FA: Altered clock
gene expression in obese visceral adipose tissue is associated with
metabolic syndrome. PLoS One. 9:e1116782014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Akashi M, Matsumura R, Matsuo T, Kubo Y,
Komoda H and Node K: Hypercholesterolemia causes circadian
dysfunction: A potential risk factor for cardiovascular disease.
EBioMedicine. 20:127–136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wood PA, Yang X and Hrushesky WJ: Clock
genes and cancer. Integr Cancer Ther. 8:303–308. 2009. View Article : Google Scholar
|
|
13
|
Zheng B, Larkin DW, Albrecht U, Sun ZS,
Sage M, Eichele G, Lee CC and Bradley A: The mPer2 gene encodes a
functional component of the mammalian circadian clock. Nature.
400:169–173. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Albrecht U, Bordon A, Schmutz I and
Ripperger J: The multiple facets of Per2. Cold Spring Harb Symp
Quant Biol. 72:95–104. 2007. View Article : Google Scholar
|
|
15
|
Toh KL, Jones CR, He Y, Eide EJ, Hinz WA,
Virshup DM, Ptácek LJ and Fu YH: An hPer2 phosphorylation site
mutation in familial advanced sleep phase syndrome. Science.
291:1040–1043. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fu L, Pelicano H, Liu J, Huang P and Lee
C: The circadian gene Period2 plays an important role in tumor
suppression and DNA damage response in vivo. Cell. 111:41–50. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wood PA, Yang X, Taber A, Oh EY, Ansell C,
Ayers SE, Al-Assaad Z, Carnevale K, Berger FG, Peña MM, et al:
Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol Cancer
Res. 6:1786–1793. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao H, Zeng ZL, Yang J, Jin Y, Qiu MZ, Hu
XY, Han J, Liu KY, Liao JW, Xu RH, et al: Prognostic relevance of
Period1 (Per1) and Period2 (Per2) expression in human gastric
cancer. Int J Clin Exp Pathol. 7:619–630. 2014.PubMed/NCBI
|
|
19
|
Lin YM, Chang JH, Yeh KT, Yang MY, Liu TC,
Lin SF, Su WW and Chang JG: Disturbance of circadian gene
expression in hepatocellular carcinoma. Mol Carcinog. 47:925–933.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Hua L, Lu C and Chen Z: Expression
of circadian clock gene human Period2 (hPer2) in human colorectal
carcinoma. World J Surg Oncol. 9:1662011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hsu CM, Lin SF, Lu CT, Lin PM and Yang MY:
Altered expression of circadian clock genes in head and neck
squamous cell carcinoma. Tumour Biol. 33:149–155. 2012. View Article : Google Scholar
|
|
22
|
Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang
C, Wang X, Wang Z, Cornelissen-Guillaume G and Halberg F: Circadian
gene mPer2 overexpression induces cancer cell apoptosis. Cancer
Sci. 97:589–596. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng AY, Zhang Y, Mei HJ, Fang S, Ji P,
Yang J, Yu L and Guo WC: Construction of a plasmid for
overexpression of human circadian gene period2 and its biological
activity in osteosarcoma cells. Tumour Biol. 36:3735–3743. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Oda A, Katayose Y, Yabuuchi S, Yamamoto K,
Mizuma M, Shirasou S, Onogawa T, Ohtsuka H, Yoshida H, Hayashi H,
et al: Clock gene mouse period2 overexpression inhibits growth of
human pancreatic cancer cells and has synergistic effect with
cisplatin. Anticancer Res. 29:1201–1209. 2009.PubMed/NCBI
|
|
25
|
Wang Q, Ao Y, Yang K, Tang H and Chen D:
Circadian clock gene Per2 plays an important role in cell
proliferation, apoptosis and cell cycle progression in human oral
squamous cell carcinoma. Oncol Rep. 35:3387–3394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Su X, Chen D, Yang K, Zhao Q, Zhao D, Lv X
and Ao Y: The circadian clock gene PER2 plays an important role in
tumor suppression through regulating tumor-associated genes in
human oral squamous cell carcinoma. Oncol Rep. 38:472–480. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chi AC, Day TA and Neville BW: Oral cavity
and oropharyngeal squamous cell carcinoma - an update. CA Cancer J
Clin. 65:401–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wan X, Li X, Yang J, Lv W, Wang Q, Chen Y
and Li Y: Genetic association between PIK3CA gene and oral squamous
cell carcinoma: A case control study conducted in Chongqing, China.
Int J Clin Exp Pathol. 8:13360–13366. 2015.
|
|
29
|
Chen Y, Hou Q, Yan W, Luo J, Chen D, Liu
Z, He S and Ding X: PIK3CA is critical for the proliferation,
invasiveness, and drug resistance of human tongue carcinoma cells.
Oncol Res. 19:563–571. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jasphin SS, Desai D, Pandit S, Gonsalves
NM, Nayak PB and Iype A: Immunohistochemical expression of
phosphatase and tensin homolog in histologic gradings of oral
squamous cell carcinoma. Contemp Clin Dent. 7:524–528. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rahmani A, Alzohairy M, Babiker AY, Rizvi
MA and Elkarimahmad HG: Clinicopathological significance of PTEN
and bcl2 expressions in oral squamous cell carcinoma. Int J Clin
Exp Pathol. 5:965–971. 2012.PubMed/NCBI
|
|
32
|
Mao C, Lu Y, Lai Q, Xia Y and Yang C:
Expression of p53 gene in oral squamous cell carcinoma and its
relation with clinical and pathological parameters and prognosis of
patients. Chin Med Sci J. 10:199–203. 1995.PubMed/NCBI
|
|
33
|
Shintani S, Nakahara Y, Mihara M, Ueyama Y
and Matsumura T: Inactivation of the p14(ARF), p15(INK4B) and
p16(INK4A) genes is a frequent event in human oral squamous cell
carcinomas. Oral Oncol. 37:498–504. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Elrod HA, Fan S, Muller S, Chen GZ, Pan L,
Tighiouart M, Shin DM, Khuri FR and Sun SY: Analysis of death
receptor 5 and caspase-8 expression in primary and metastatic head
and neck squamous cell carcinoma and their prognostic impact. PLoS
One. 5:e121782010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin J and Zhu MH: Interactive pathway of
ARF-mdm2-p53. Ai Zheng. 22:328–330. 2003.In Chinese. PubMed/NCBI
|
|
36
|
Liu J, Zhang C and Feng Z: Tumor
suppressor p53 and its gain-of-function mutants in cancer. Acta
Biochim Biophys Sin (Shanghai). 46:170–179. 2014. View Article : Google Scholar
|
|
37
|
Gröbe A, Hanken H, Al-Dam A, Cachovan G,
Smeets R, Krohn A, Clauditz T, Grob T, Simon R, Sauter G, et al:
P53 immunohistochemical expression does not correlate with clinical
features in 207 carcinomas of the oral cavity and in the head and
neck region. Clin Oral Investig. 18:211–217. 2014. View Article : Google Scholar
|
|
38
|
Friedrich RE, Giese M, Riethdorf S and
Loning T: P53-mutation in smears of oral squamous cell carcinoma.
Anticancer Res. 20D:4927–4930. 2000.
|
|
39
|
Takami H, Yoshida A, Fukushima S, Arita H,
Matsushita Y, Nakamura T, Ohno M, Miyakita Y, Shibui S, Narita Y,
et al: Revisiting TP53 mutations and immunohistochemistry - A
comparative study in 157 diffuse gliomas. Brain Pathol. 25:256–265.
2015. View Article : Google Scholar
|
|
40
|
Lai K, Killingsworth MC and Lee CS: Gene
of month: PIK3CA. J Clin Pathol. 68:253–257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lee JO, Yang H, Georgescu MM, Di
Cristofano A, Maehama T, Shi Y, Dixon JE, Pandolfi P and Pavletich
NP: Crystal structure of the PTEN tumor suppressor: Implications
for its phosphoinositide phosphatase activity and membrane
association. Cell. 99:323–334. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Di Cristofano A and Pandolfi PP: The
multiple roles of PTEN in tumor suppression. Cell. 100:387–390.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen B, Tan Y, Liang Y, Li Y, Chen L, Wu
S, Xu W, Wang Y, Zhao W and Wu J: Per2 participates in AKT-mediated
drug resistance in A549/DDP lung adenocarcinoma cells. Oncol Lett.
13:423–428. 2017.PubMed/NCBI
|
|
44
|
Wang Z, Li L and Wang Y: Effects of Per2
overexpression on growth inhibition and metastasis, and on MTA1,
nm23-H1 and the autophagy-associated PI3K/PKB signaling pathway in
nude mice xenograft models of ovarian cancer. Mol Med Rep.
13:4561–4568. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fulda S: Caspase-8 in cancer biology and
therapy. Cancer Lett. 281:128–133. 2009. View Article : Google Scholar
|
|
46
|
Wang X, Fu Z, Chen Y and Liu L: Fas
expression is downregulated in gastric cancer. Mol Med Rep.
15:627–634. 2017. View Article : Google Scholar :
|
